Table 1.
Baseline characteristics of patients with ischemic stroke with nonvalvular atrial fibrillation treated with new oral anticoagulants and patients without atrial fibrillation.
| Parameter | AF NOAC (n = 256) | No-AF (n = 1776) | p-Value |
|---|---|---|---|
| Age, mean ± SD; Me | 78.23 ± 7.32; 79.0 | 68.66 ± 8.41; 69.0 | <0.001 |
| Female, n (%) | 181 (70) | 893 (50) | <0.001 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | 134 (52) | 551 (31) | <0.001 |
| Dyslipidemia | 152 (59) | 724 (40) | <0.001 |
| Hypertension | 237 (92) | 1306 (73) | <0.001 |
| ICA significant stenosis/occlusion | 43 (16) | 255 (14) | 0.302 |
| Coronary heart disease | 166 (64) | 707 (39) | <0.001 |
| Peripheral arterial disease | 51 (19) | 211 (11) | <0.001 |
| Smoking | 151 (58) | 890 (50) | 0.008 |
| Previous stroke | 161 (62) | 793 (44) | <0.001 |
Legend: n—number of patients, SD—standard deviation, Me—median, AF—atrial fibrillation, ICA —internal carotid artery, NOAC—nonvalvular atrial fibrillation treated with new oral anticoagulants.